Corcept Therapeutics Inc CORT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
28.09UNCH (UNCH)
Volume
24,031
Close
28.09quote price arrow up+0.55 (+2.00%)
Volume
799,727
52 week range
20.84 - 34.28
Loading...
  • Open27.57
  • Day High28.33
  • Day Low27.53
  • Prev Close27.54
  • 52 Week High34.28
  • 52 Week High Date09/14/23
  • 52 Week Low20.84
  • 52 Week Low Date04/22/24

Key Stats

  • Market Cap2.925B
  • Shares Out104.11M
  • 10 Day Average Volume1.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.44
  • YTD % Change-13.52

KEY STATS

  • Open27.57
  • Day High28.33
  • Day Low27.53
  • Prev Close27.54
  • 52 Week High34.28
  • 52 Week High Date09/14/23
  • 52 Week Low20.84
  • 52 Week Low Date04/22/24
  • Market Cap2.925B
  • Shares Out104.11M
  • 10 Day Average Volume1.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.44
  • YTD % Change-13.52

RATIOS/PROFITABILITY

  • EPS (TTM)1.07
  • P/E (TTM)26.27
  • Fwd P/E (NTM)29.51
  • EBITDA (TTM)122.919M
  • ROE (TTM)21.91%
  • Revenue (TTM)523.529M
  • Gross Margin (TTM)98.54%
  • Net Margin (TTM)22.54%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Corcept Therapeutics Inc

 

Profile

MORE
Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients...
James Wilson
Independent Chairman of the Board
Joseph Belanoff M.D.
President, Chief Executive Officer, Co-Founder, Director
Atabak Mokari
Chief Financial Officer, Treasurer
Joseph Lyon
Chief Technology Officer, Chief Accounting Officer
Address
149 Commonwealth Dr
Menlo Park, CA
94025
United States

Top Peers

SYMBOLLASTCHG%CHG
AMPH
Amphastar Pharmaceuticals Inc
43.48+0.74+1.73%
HRMY
Harmony Biosciences Holdings Inc
29.03-0.28-0.96%
SUPN
Supernus Pharmaceuticals Inc
29.10-0.06-0.21%
ANIP
ANI Pharmaceuticals Inc
61.43-2.34-3.67%
PCRX
Pacira Biosciences Inc
30.82-0.69-2.19%